External evaluation of population pharmacokinetic models for continuous administration of meropenem in critically ill adult patients

Impact of Inaccurate Documentation of Sampling and Infusion Time in Model-Informed Precision Dosing

(2020) Dzenefa Alihodzic et al.   Frontiers in Pharmacology

Towards precision dosing of vancomycin: A systematic evaluation of pharmacometric models for Bayesian forecasting

(2019) A. Broeker et al.   CLINICAL MICROBIOLOGY AND INFECTION

Development of a dosing nomogram for continuous-infusion meropenem in critically ill patients based on a validated population pharmacokinetic model

(2018) Iris K Minichmayr et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models

(2018) Sofie A M Dhaese et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Maximally effective dosing regimens of meropenem in patients with septic shock

(2017) Fredrik Sjövall et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies

(2016) Amélie Marsot et al.   CLINICAL PHARMACOKINETICS

Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients

(2016) Francesca Mattioli et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Antibiotic-associated encephalopathy

(2016) Shamik Bhattacharyya et al.   NEUROLOGY

A Nonparametric Pharmacokinetic Approach to Determine the Optimal Dosing Regimen for 30-Minute and 3-Hour Meropenem Infusions in Critically Ill Patients

(2016) Sumith K. Mathew et al.   THERAPEUTIC DRUG MONITORING

Population Pharmacokinetics and Monte Carlo Dosing Simulations of Meropenem during the Early Phase of Severe Sepsis and Septic Shock in Critically Ill Patients in Intensive Care Units

(2015) Sutep Jaruratanasirikul et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Population pharmacokinetics of meropenem during continuous infusion in surgical ICU patients

(2015) Martin G. Kees et al.   JOURNAL OF CLINICAL PHARMACOLOGY

Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions

(2014) Jason A Roberts et al.   LANCET INFECTIOUS DISEASES

External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

(2012) Wei Zhao et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Population pharmacokinetics of four β-lactams in critically ill septic patients comedicated with amikacin

(2012) Isabelle K. Delattre et al.   CLINICAL BIOCHEMISTRY

The Clinical Relevance of Plasma Protein Binding Changes

(2012) Jason A. Roberts et al.   CLINICAL PHARMACOKINETICS

Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia

(2011) T. P. Lodise et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Simultaneous Determination of 12 β-Lactam Antibiotics in Human Plasma by High-Performance Liquid Chromatography with UV Detection: Application to Therapeutic Drug Monitoring

(2011) Marie-Clémence Verdier et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

(2011) Joo Yeon Lee et al.   CLINICAL PHARMACOKINETICS

Pharmacokinetics and pharmacodynamics in critically ill patients

(2010) Julie M Varghese et al.   Current Opinion in Anesthesiology

Optimization of meropenem dosage in the critically ill population based on renal function

(2010) Jared L. Crandon et al.   INTENSIVE CARE MEDICINE

Population Pharmacokinetic Modeling and Optimal Sampling Strategy for Bayesian Estimation of Amikacin Exposure in Critically Ill Septic Patients

(2010) Isabelle K Delattre et al.   THERAPEUTIC DRUG MONITORING

Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution

(2009) Jason A. Roberts et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE